ITHACA, N.Y. — Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors. “I am delighted to welcome Dr. Thomas to the Rheonix Board and as our Chief Medical Officer,” said Greg Galvin, President, CEO […]
MENLO PARK, Calif. – PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff Eidel as Chief Commercial Officer, effective August 16, 2022. In this role, Mr. Eidel will have global responsibility for all commercial activity including sales, marketing, and customer support. “Jeff is a strong leader and […]
QIAGEN Clinical Insights platform growing at over 35% annually, or 700,000 additional cases, and recently breaking through three million cases analyzed and reported Total number of analyzed and reported patient cases using QCI five times higher than other commercial offerings Unique Augmented Molecular Intelligence approach provides customers with the ability to scale NGS testing with […]
LONGMONT, Colo. — KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of their dGH™ Cell Prep Kit for use in their dGH in-Site™ and dGH SCREEN™ assays. KromaTiD has been providing high-resolution assays with superior detection, and robust data […]
PROVIDENCE RI — Nabsys, the pioneer in electronic whole-genome mapping, announced the appointment of Kevin DeGeeter as Chief Financial Officer. “I am excited to welcome Kevin to the executive team,” said Barrett Bready, MD, Nabsys Founder and CEO. “Kevin’s deep understanding of the genomics space, as well as his reputation among investors and operators as […]
Global conference to focus on advancing the transformative impacts of genomic health SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that former President of the United States Barack Obama will participate in a moderated Q&A conversation at the inaugural Illumina Genomics Forum, the company’s global event focused […]
Porvair Sciences has introduced a 96-well deep well microplate designed for labs using magnetic beads for nucleic acid purification, clean up and protein purifications. The 96-well magnetic bead separation plate has a reinforced base that can be routinely centrifuged at up to 6,000x g enabling faster magnetic bead separation protocols and improved sample quality. Manufactured in […]
The Science Based Targets initiative has validated Illumina’s targets to reach Net-Zero greenhouse gas emissions by 2050 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi). […]
PLEASANTON, Calif. — Following a comprehensive search process, 10x Genomics, Inc. (Nasdaq: TXG), today announced the hiring of Jim Wilbur, Ph.D., as Chief Commercial Officer, effective July 27. In this role, Wilbur will be responsible for driving commercial strategy and execution and leading the company’s sales, support and marketing functions. A life sciences entrepreneur and seasoned […]
Expands bioanalytical services to include many emerging areas worldwide MALVERN, Pa. – Alliance Pharma (Alliance), a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, today closed on the purchase of Drug Development Solutions (DDS), a U.K.-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital Partners, a global healthcare […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
